Applying the Public Health Exposome Model to Improve Kidney Disease Outcomes for Patients and Populations

Applying the Public Health Exposome Model to Improve Kidney Disease Outcomes for Patients and Populations

Identification: nnj_nd_18A5
Issue: November-December 2018
Volume: Vol. 45, No. 6
Credits (Post Test and/or Evaluation Required)
Available until 12/31/2020
  • 1.30 - CH

Standard: $30.00


Contact hours available until 12/31/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Nephrology Nursing Journal Editorial Board Statements of Disclosure:
In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.

Paula Dutka, MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.

Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.

Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a member of the ANNA Board of Directors, serves on the Scientific Advisory Board for Kibow Biotech, Inc., and is employed by Fresenius Kidney Care as an acute hemodialysis RN.

All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.

This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP, ANNA Education Director.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.

The content and views expressed in this article are those of the authors and do not necessarily reflect the position, policy, endorsement, or interpretation of the United States government or state government.

Learning Outcome:

After completing this learning activity, the learner will be able to examine kidney disease with a Public Health Exposome Model and gain a deeper understanding of the dynamic relationship among the individual, environment, moderating factors, and individual and population health outcomes; nurses will be able to uncover meaningful interventions for reducing incidence of kidney disease and improving health outcomes for patients with chronic kidney disease and kidney failure in their communities.

Learning Engagement Activity:

For more information on Exposome and work in this area, visit The Human Exposome Project


Credits Available

Expired On: Dec 31, 2020

You must be logged in and own this product in order to post comments.